Axsome Therapeutics, Inc.
Clinical trials sponsored by Axsome Therapeutics, Inc., explained in plain language.
-
New pill could curb binge eating episodes
Disease control Recruiting nowThis study tests a medication called solriamfetol to see if it can reduce binge eating episodes in adults with binge eating disorder. About 450 people will take either the drug or a placebo for 12 weeks. The main goal is to see if the number of binge episodes decreases compared t…
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New pill could help night shift workers fight off sleepiness
Symptom relief Recruiting nowThis study tests a medication called solriamfetol to see if it can reduce excessive sleepiness in adults with shift work disorder. About 520 people will receive either the drug or a placebo for 12 weeks. The goal is to measure how well they stay awake during night shifts and how …
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 17, 2026 04:35 UTC
-
New hope for tired minds: drug targets sleepiness in depression
Symptom relief Recruiting nowThis study tests whether solriamfetol can help people with major depression who also feel very sleepy during the day. About 508 adults will take the drug or a placebo to see if it delays the return of depressive symptoms. The goal is to improve energy and mood without requiring l…
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 17, 2026 04:33 UTC
-
New fibromyalgia drug shows promise in major trial
Symptom relief Recruiting nowThis study tests an experimental drug called AXS-14 for managing fibromyalgia, a condition that causes widespread pain and fatigue. About 620 adults with fibromyalgia will take the drug or a placebo to see if it helps control symptoms longer. The main goal is to measure how long …
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC